Wednesday, October 31, 2018 2:57:16 PM
...from the latest CC:
"As far as poultry, we have been struggling, as I think we've discussed in the past, with the fact that at 160 ppm, which is where we had to go in order to generate the efficacy that we wanted on poultry parts, at 160 ppm, PURE Control is significantly more expensive ounce per ounce versus existing interventions that are being used like peracetic acid. Now we do believe that we have a compelling value proposition because we're nontoxic, they're highly toxic. We do not corrode equipment, they corrode equipment. We don't contaminate the waste water as they do. We're not an irritant to employees. And we have a positive to neutral impact on yield, and theirs is negative. All of that being said, that hasn't been enough to date to offset the cost differential. So we are continuing to work on trying to optimize the ppm, see if we can achieve acceptable efficacy at a lower ppm and therefore a lower cost. We're also working to optimize the amount of PURE Control that is applied per application or the flow rate. If we can reduce the flow rate, we can also reduce the cost. So those are the areas that we're working on. We're wrestling with it. We're not there yet. And we hope to have some better learning and more encouraging results in the coming months."
Recent PURE News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:30:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/10/2024 09:30:10 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/19/2023 09:45:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 09:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:05:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/30/2023 08:10:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:05:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:23:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:20:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:19:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:17:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:14:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:13:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:30:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM